UBS Group’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49K | Buy |
11,255
+11,254
| +1,125,400% | +$3.49K | ﹤0.01% | 8026 |
|
|
2025
Q1 | $0 | Sell |
1
-41,111
| -100% | – | ﹤0.01% | 8921 |
|
|
2024
Q4 | $28.8K | Sell |
41,112
-156,747
| -79% | -$110K | ﹤0.01% | 6409 |
|
|
2024
Q3 | $92.8K | Buy |
+197,859
| New | +$92.8K | ﹤0.01% | 5234 |
|
|
2023
Q3 | – | Sell |
-610
| Closed | -$1.12K | – | 8329 |
|
|
2023
Q2 | $1.12K | Buy |
+610
| New | +$1.12K | ﹤0.01% | 6926 |
|
|
2023
Q1 | – | Sell |
-5,543
| Closed | -$11.6K | – | 8517 |
|
|
2022
Q4 | $11.6K | Buy |
5,543
+2,358
| +74% | +$4.95K | ﹤0.01% | 7181 |
|
|
2022
Q3 | $6K | Buy |
3,185
+2,286
| +254% | +$4.31K | ﹤0.01% | 7903 |
|
|
2022
Q2 | $2K | Sell |
899
-2,850
| -76% | -$6.34K | ﹤0.01% | 8472 |
|
|
2022
Q1 | $10K | Hold |
3,749
| – | – | ﹤0.01% | 7343 |
|
|
2021
Q4 | $24K | Buy |
+3,749
| New | +$24K | ﹤0.01% | 6508 |
|